BeStock  

Twist Bioscience TWST

US equityMarket cap rank #1743AI medical concept stocks
$103.32 −$8.30 (-7.44%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $105.01 +1.64%
Open$108.39
Prev close$111.62
Day range$101.00 – $108.50
Volume3.38M
Market cap$6.85B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q4, ended Sep 2026

Revenue$126.64M+27.9% YoY
Operating profit-$24.41M+18.4% YoY
Net profit-$20.62M+24.0% YoY
Diluted EPS-$0.32+28.9% YoY
Free cash flow-$26.98M-11.3% YoY
Operating cash flow-$173,000.00

Revenue, last 8 quarters

$88.7MDec '24$92.8MMar '25$96.1MJun '25$99.0MSep '25$103.7MDec '25$110.7MMar '26$118.4MJun '26$126.6MSep '26

Net profit, last 8 quarters

$-31.6MDec '24$-39.3MMar '25$20.4MJun '25$-27.1MSep '25$-30.5MDec '25$-44.0MMar '26$-35.1MJun '26$-20.6MSep '26

Diluted EPS by quarter

-0.53Dec '24-0.66Mar '250.33Jun '25-0.45Sep '25-0.50Dec '25-0.71Mar '26-0.56Jun '26-0.32Sep '26

Free cash flow by quarter

$-23.7MDec '24$-17.1MMar '25$-10.6MJun '25$-24.2MSep '25$-34.8MDec '25$-25.5MMar '26$-8.6MJun '26$-27.0MSep '26

Annual revenue

$132.3MFY21$203.6MFY22$245.1MFY23$313.0MFY24$376.6MFY25$459.4MFY26

Profitability & balance sheet

Gross margin52.4%
Operating margin-28.8%
Net margin-28.3%
Return on equity-19.1%
Return on assets-14.8%
Return on invested capital-17.7%
Current ratio5.86
Liabilities / assets20.8%
Cash & investments$581.91M
Total debt$86.54M
Net cash (debt)$495.37M

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Next-Generation Sequencing (NGS) applications$61.81M 52.2%
  • DNA synthesis and protein solutions$56.57M 47.8%

Income statement

Line item 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2 2026 Q1
Total Revenue as Reported $459.43M $126.64M $118.38M $110.72M $103.70M
Total Operating Revenue $459.43M $126.64M $118.38M $110.72M $103.70M
Cost of Revenue $218.63M $59.39M $55.92M $53.59M $49.73M
Gross Profit $240.80M $67.25M $62.45M $57.12M $53.97M
Operating Expense $373.05M $91.67M $98.73M $95.78M $87.07M
Selling and Admin Expenses $301.22M $74.68M $80.71M $76.09M $69.94M
Research & Development $71.84M $16.99M $18.03M $19.70M $17.13M
Operating Profit -$132.25M -$24.41M -$36.28M -$38.66M -$33.10M
Net Non-Operating Interest Income (Expense) $8.80M $3.42M $1.50M $1.71M $2.18M
Non-Operating Interest Income $8.80M $3.42M $1.50M $1.71M $2.18M
Other Income (Expense) -$6.35M $170,000.00 $40,000.00 -$7.03M $671,000.00
Special Income (Charges) -$7.21M $0.00 $0.00 -$7.21M –
-Less:Impairment of Capital Assets $0.00 – – – –
-Less:Other Special Charges $7.21M $0.00 – $7.21M –
-Gain on Sale Of Business $0.00 $0.00 $0.00 – –
Other Non-Operating Income (Expenses) $856,000.00 $170,000.00 $40,000.00 $175,000.00 $671,000.00
Pretax Profit -$129.80M -$20.82M -$34.74M -$43.98M -$30.25M
Tax $406,000.00 -$201,000.00 $311,000.00 $43,000.00 $253,000.00
Net Profit -$130.20M -$20.62M -$35.05M -$44.02M -$30.51M
Profit from Continuing Operations -$130.20M -$20.62M -$35.05M -$44.02M -$30.51M
Net Income to Parent Company -$130.20M -$20.62M -$35.05M -$44.02M -$30.51M
Net Income to Common Stockholders -$130.20M -$20.62M -$35.05M -$44.02M -$30.51M
Basic EPS -$2.08 -$0.32 -$0.56 -$0.71 -$0.50
Diluted EPS -$2.08 -$0.32 -$0.56 -$0.71 -$0.50

Balance sheet

Line item 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2 2026 Q1
Total Assets $1.12B $1.12B $672.44M $676.21M $638.09M
Total Current Assets $737.22M $737.22M $321.30M $323.44M $303.88M
Cash and Cash Equivalents & Short-Term Investments $581.91M $581.91M $166.84M $171.67M $197.95M
-Cash and Cash Equivalents $533.99M $533.99M $117.44M $122.67M $148.59M
-Short Term Investments $47.92M $47.92M $49.40M $49.00M $49.36M
Receivables $93.42M $93.42M $87.58M $87.45M $50.06M
-Accounts Receivable $70.19M $70.19M $65.06M $64.15M $50.06M
-Other Receivables $23.22M $23.22M $22.53M $23.30M –
Prepaid Assets $11.38M $11.38M $9.96M $9.34M –
Inventory $46.41M $46.41M $35.16M $33.52M $32.92M
Restricted Cash $1.65M $1.65M – – –
Other Current Assets $2.46M $2.46M $21.75M $21.47M $22.95M
Total Non-Current Assets $384.58M $384.58M $351.14M $352.78M $334.20M
Net PPE $191.60M $191.60M $180.62M $181.88M $177.39M
-Gross PPE $309.95M $309.95M $292.33M $287.79M $277.55M
-Accumulated Depreciation -$118.35M -$118.35M -$111.71M -$105.91M -$100.17M
Investments and Advances $68.09M $68.09M $68.09M $68.09M $54.34M
-Available for Sale Securities $68.09M $68.09M $68.09M $68.09M $54.34M
Goodwill and Other Intangible Assets $116.36M $116.36M $94.93M $95.19M $95.36M
-Goodwill $82.20M $82.20M $82.20M $82.20M $82.20M
-Other Intangible Assets $34.16M $34.16M $12.73M $13.00M $13.16M
Other Non-Current Assets $8.54M $8.54M $7.51M $7.62M $7.12M
Total Liabilities $233.79M $233.79M $226.70M $221.12M $181.99M
Total Current Liabilities $125.81M $125.81M $120.26M $119.98M $80.44M
Payables $33.06M $33.06M $24.42M $19.66M $16.39M
-Accounts Payable $24.85M $24.85M $17.04M $14.68M $12.49M
-Total Tax Payable $8.21M $8.21M $7.38M $4.98M $3.90M
Current Accrued Expenses $38.91M $38.91M $40.18M $45.51M $23.41M
Short-Term Debt and Capital Lease Obligation $8.45M $8.45M $8.63M $10.44M $12.24M
-Current Capital Lease Obligation $8.45M $8.45M $8.63M $10.44M $12.24M
Current Deferred Liabilities $7.02M $7.02M $6.47M $7.10M $9.02M
Other Current Liabilities $49,000.00 $49,000.00 $5.68M $10.26M $548,000.00
Total Non-Current Liabilities $107.98M $107.98M $106.44M $101.14M $101.55M
Long Term Debt and Capital Lease Obligation $86.54M $86.54M $84.96M $85.40M $85.81M
-Long Term Capital Lease Obligation $86.54M $86.54M $84.96M $85.40M $85.81M
Non-Current Deferred Liabilities $15.00M $15.00M $15.00M $15.00M $15.00M
Other Non-Current Liabilities $6.45M $6.45M $6.48M $746,000.00 $741,000.00
Total Equity $888.02M $888.02M $445.74M $455.09M $456.10M
Stockholders' Equity $888.02M $888.02M $445.74M $455.09M $456.10M
Capital Stock $1,000.00 $1,000.00 $1,000.00 $1,000.00 $0.00
-Common Stock $1,000.00 $1,000.00 $1,000.00 $1,000.00 $0.00
Additional Paid-In Capital $2.34B $2.34B $1.88B $1.85B $1.81B
Retained Earnings -$1.45B -$1.45B -$1.43B -$1.39B -$1.35B
Gains/Losses Not Affecting Retained Earnings -$680,000.00 -$680,000.00 -$655,000.00 -$639,000.00 -$571,000.00

Cash flow

Line item 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2 2026 Q1
Operating Cash Flow -$41.43M -$173,000.00 $1.12M -$17.56M -$24.81M
Net cash flow from continuing operations -$41.43M -$173,000.00 $1.12M -$17.56M -$24.81M
Net Income from Continuing Operations -$130.20M -$20.62M -$35.05M -$44.02M -$30.51M
Depreciation & Depletion & Amortization $26.48M $7.10M $6.78M $6.41M $6.19M
Other Non-Cash Items $265,000.00 $938,000.00 $161,000.00 -$498,000.00 -$336,000.00
Change in Working Capital -$7.83M -$7.06M $11.05M $1.61M -$13.44M
-Change in Receivables -$13.80M -$5.30M -$1.09M -$14.24M $6.83M
-Change in Inventory -$18.10M -$11.25M -$1.65M -$590,000.00 -$4.62M
-Change in Prepaid Assets -$21.78M -$2.82M -$99,000.00 -$11.13M -$7.74M
-Change in Payables and Accrued Expense $47.29M $13.45M $13.77M $29.52M -$9.46M
-Change in Other Current Assets -$1.44M -$1.13M $114,000.00 -$641,000.00 $225,000.00
Net cash flow from investing -$53.09M -$20.25M -$10.20M -$12.71M -$9.93M
Net Cash Flow from Continuing Investing Activities -$53.09M -$20.25M -$10.20M -$12.71M -$9.93M
Net PPE Purchase and Sale -$47.58M -$19.96M -$9.76M -$7.89M -$9.97M
Net Intangibles Purchase and Sale -$6.95M -$6.85M $0.00 – –
Net Business Purchase and Sale $0.00 $5.00M $0.00 – –
Net Investment Purchase and Sale $1.45M $1.56M -$435,000.00 $281,000.00 $41,000.00
Financing Cash Flow $446.68M $438.46M $3.79M $4.14M $298,000.00
Net Cash Flow from Continuing Financing Activities $446.68M $438.46M $3.79M $4.14M $298,000.00
Net Common Stock Issuance $424.79M $424.80M -$6,000.00 -$8,000.00 -$2,000.00
Proceeds from Stock Option Exercised $21.89M $13.65M $3.79M $4.15M $300,000.00
Ending Cash Balance $537.61M $537.61M $119.57M $124.85M $150.99M
Net Change in Cash $352.16M $418.03M -$5.30M -$26.13M -$34.45M
Beginning Cash Balance $185.43M $119.57M $124.85M $150.99M $185.43M
Effect of Exchange Rate Changes $24,000.00 $11,000.00 $10,000.00 -$6,000.00 $9,000.00
Free Cash Flow -$95.96M -$26.98M -$8.65M -$25.55M -$34.79M
-Change in Other Current Liabilities – – – – $1.32M

Discussion

No comments yet — be the first to weigh in on TWST.

Sign in to join the discussion.

Scroll to Top